Education
About Us
Working with TipRanks
Follow Us
SPDR S&P BIOTECH ETF (XBI)
NYSEARCA:XBI
XBI Analyst Ratings
Moderate Buy
1079 Buy
233 Hold
25 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
XBI Stock 12 Month Forecast
Average Price Target
$151.75
▲(65.06% Upside)
| Highest Price Target$214.53 | Average Price Target$151.75 | Lowest Price Target$102.89 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
XBI Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
XBI Financial Forecast
XBI Stock Forecast FAQ
What is XBI’s average 12-month price target, according to analysts?
Based on analyst ratings, SPDR S&P BIOTECH ETF’s 12-month average price target is $151.75.
What is XBI’s upside potential, based on the analysts’ average price target?
SPDR S&P BIOTECH ETF has 65.06% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is XBI a Buy, Sell or Hold?
SPDR S&P BIOTECH ETF has a consensus rating of Moderate Buy which is based on 1079 buy ratings, 233 hold ratings and 25 sell ratings.
What is SPDR S&P BIOTECH ETF’s price target?
The average price target for SPDR S&P BIOTECH ETF is $151.75. This is based on 1337 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $214.53 ,the lowest forecast is $102.89. The average price target represents 65.06% Increase from the current price of $91.94.
The highest analyst price target is $214.53 ,the lowest forecast is $102.89. The average price target represents 65.06% Increase from the current price of $91.94.
What do analysts say about SPDR S&P BIOTECH ETF?
SPDR S&P BIOTECH ETF’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1337 Wall Streets Analysts.
How can I buy shares of XBI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.